Call for papers
The Electronic Conferences on Synthetic Organic Chemistry (ECSOC) are a series of conferences that have been held online since 1997. Originally, it was an initiative of MDPI, and was later amalgamated with the University of Santiago de Compostela (Spain). It now constitutes the longest running electronic conference in the world. It maintains free participation and registration in the true spirit of open access on the World Wide Web. The conference this year will cover a wide range of aspects involved in synthetic organic chemistry. A non-exhaustive list of topics that will be considered comprises:
- General Organic Synthesis
- Bioorganic, Medicinal and Natural Products Chemistry
- Microwave Assisted Synthesis
- Polymer and Supramolecular Chemistry
- Computational Chemistry
- Ionic Liquids
ECSOC22 offers you the opportunity to participate in this international, scholarly conference without having the concern or expenditure of travel. The conference will be completely free of charge—both to “attend”, and for scholars to upload and present their latest work on the conference platform. There will be a possibility to submit selected papers to the journal Molecules (ISSN 1420-3049, Impact Factor: 3.098 (2017) ; 5-Year Impact Factor: 3.268 (2017); http://www.mdpi.com/journal/molecules).
Abstracts (in English) should be submitted by *15 October 2018* online at https://sciforum.net/conference/ecsoc-22. After the abstract is accepted by the Scientific Committee, the authors will be invited to prepare a full description of their work under the form of a PowerPoint presentation, and to upload it *before 10 November 2018* to ensure there is time for a final check.
We hope you will be able to join this exciting event and support us in making it a success. The 22nd International Electronic Conference on Synthetic Organic Chemistry is organized and sponsored by MDPI (http://www.mdpi.com), an open access publisher based in Switzerland.
We look forward to receiving your research papers and to welcome you at this 22nd edition of the e-Conference.
Please do not hesitate to contact us if you have questions.
*Dr. Julio A. Seijas Vázquez*
Chair of the 22nd Electronic Conference on Synthetic Organic Chemistry (ECSOC 22)
Dr. Julio A. Seijas
Universidad de Santiago de Compostela
Instructions for Authors
- Scholars interested in participating with the conference can submit their abstract (about 200-250 words covering the areas of manuscripts for the proceedings issue) online on this website until 15 October 2018.
- The Conference Committee will pre-evaluate, based on the submitted abstract, whether a contribution from the authors of the abstract will be welcome for the 22nd International Electronic Conference on Synthetic Organic Chemistry. All authors will be notified by 25 October 2018 about the acceptance of their abstract.
- If the abstract is accepted for this conference, the author is asked to submit the manuscript, optionally along with a PowerPoint and/or video presentation of his/her paper (only PDF), until the submission deadline of 10 November 2018.
- The conference proceedings papers and presentations will be available on https://sciforum.net/conference/ecsoc-22 for discussion.
- Accepted papers will be published in the proceedings of the conference and the Open Access Journal Molecules will publish the proceedings of the conference as a Special Issue.
Manuscripts for the proceedings issue must have the following organization:
Full author names
Affiliations (including full postal address) and authors' e-mail addresses
Abstract (200-250 words)
Results and Discussion
Manuscripts should be prepared in MS Word or any other word processor and should be converted to the PDF format before submission. The publication format will be PDF.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the Manuscript. Slides, if available, will be displayed directly in the website using Sciforum.net's proprietary slides viewer. Slides can be prepared in exactly the same way as for any traditional conference where research results can be presented. Slides should be converted to the PDF format before submission so that our process can easily and automatically convert them for online displaying.
Besides their active participation within the forum, authors are also encouraged to submit video presentations. The video should be no longer than 20 minutes and be prepared with the following formats,
Submission of Manuscripts
Submission: Manuscripts should be submitted online at https://sciforum.net/conferences by registering and logging in to this website.
Accepted File Formats
MS Word: Manuscript prepared in MS Word must be converted into a single file before submission. When preparing manuscripts in MS Word, the Electronic Conference on Synthetic Organic Chemistry Microsoft Word template file (see download below) must be used. Please do not insert any graphics (schemes, figures, etc.) into a movable frame which can superimpose the text and make the layout very difficult.
Paper Format: A4 paper format, the printing area is 17.5 cm x 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
Formatting / Style: Papers should be prepared following the style of ECSOC 2017 template. The full titles and the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example  or [1-3], and all the references should be listed separately and as the last section at the end of the manuscript.
Authors List and Affiliation Format: Authors' full first and last names must be given. Abbreviated middle name can be added. For papers written by various contributors a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties, who provided only minor contributions, should be listed under Acknowledgments only. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
Figures, Schemes and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Figure and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and a explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, a figure or a scheme.
Potential Conflicts of Interest
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here "The authors declare no conflict of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed under "Acknowledgments" section.
MDPI AG, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Communication paper to this conference, you retain the copyright of your paper, but you grant MDPI AG the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
List of accepted submissions (89)
|sciforum-022131||"Comparative antiinflammatory activity of aeril extracts of Punica granatum fruits"||Sandeep Waghulde, Sweety Bhopi, Trunali Ghude, Roshani Gotarane||N/A||
Anti-inflammatory is the property of a substance or treatment that reduces inflammation or swelling. The main objective of this study is to evaluate Anti-inflammatory activity of pomegranate arills extract on Rat’s Paw. Anti-inflammatory activity of pomegranate was tested on rats by employing induced Carrageenan rat Paw Edema Method. Various concentrations of the arils and arils mixture (1:1) prepared by dissolving in Hydroalcohol and alcohol to obtain a final concentration of 100mg/kg, 200mg/kg, 400mg/kg against the test organisms. The effectivity of Granatin B to aqueous and alcoholic extracts arils of Punica granatum calculated by measuring the increase in paw volume and percent inhibition by comparing With control And Standard drug.
|sciforum-022351||A One-pot process for the synthesis of Alkyne-3-tretrazolyl-tetrazolo [1,5-a] quinolines.||Sandra Cecilia Ramírez López, Murali Venkata Basavanag Unnamatla, María del Rocio Gámez Montaño||N/A||
An efficient synthesis of alkyne-3-tetrazolyl-Tetrazolo[1,5-a] quinolone via a one-pot process: I-MCR Ugi-azide /SNAr/ ring-chain azido tautomerization under ecofriendly conditions. We report the one-pot synthesis of tris-heterocycles containing the tetrazolo[1,5-a]quinoline bound with 1,5-disubstituted-tetrazole (1,5-DS-T). The synthesis of this compounds can be of high interest for synthetic and medicinal chemistry because all the heterocycles are considered privilegied scaffolds and could lead to the discovery of novel bioactive molecules.
|sciforum-022298||A general stereoselective approach to 1,2,4-triazepane-3-thiones/ones via reduction or reductive alkylation of 2,4,5,6-tetrahydro-3H-1,2,4-triazepine-3-thiones/ones||Anastasia Fesenko, Anatoly Shutalev||N/A||
A general stereoselective approach to previously unknown 1,2,4-triazepane-3-thiones/ones based on reduction or reductive alkylation of readily available 2,4,5,6-tetrahydro-3H-1,2,4-triazepine-3-thiones/ones has been developed. The approach involved treatment of tetrahydrotriazepines with sodium cyanoborohydride in MeOH at pH 3 or with sodium borohydride and excess of carboxylic acid in THF to give 1-unsubstituted or 1-alkyl-substituted 1,2,4-triazepane-3-thiones/ones, respectively. The latter were also prepared by reaction of 1-unsubstituted 1,2,4-triazepane-3-thiones/ones with sodium cyanoborohydride and aldehyde in MeOH in the presence of AcOH.
|sciforum-022290||A new approach to 5-functionalized 1,2-dihydropyrimidin-2-ones/imines via base-induced chloroform elimination from 4-trichloromethyl-1,2,3,4-tetrahydropyrimidin-2-ones/imines||Pavel Solovyev, Anastasia Fesenko, Anatoly Shutalev||N/A||
A novel four-step methodology for the synthesis of 5-acyl- and 5-arylsulfonyl-1,2-dihydropyrimidin-2-ones has been developed. The reaction of readily available N-[(1-acetoxy-2,2,2-trichloro)ethyl]ureas with Na-enolates of 1,3-diketones, beta-oxoesters, or alpha-arylsulfonylketones followed by heterocyclization-dehydration of the oxoalkylureas formed gave 5-acyl- or 5-arylsulfonyl-4-trichloromethyl-1,2,3,4-tetrahydropyrimidin-2-ones. The latter, in the presence of strong bases, eliminate CHCl3 to give the target compounds. The above methodology was also used in the synthesis of 5-acyl-1,2-dihydropyrimidin-2-imines starting from N-[(1-acetoxy-2,2,2-trichloro)ethyl]-N′-guanidine.
|sciforum-022296||A new approach to the synthesis of functionalized bicyclo[3.2.1]octanes||Arif Ismiev, Gunay Mamedova, Victor Dotsenko, Nikolai Aksenov, Inna Aksenova, Abel Magerramov||N/A||
The reaction of furfural with secondary amines and isopropyl cyanoacetate leads to the formation of the previously unknown diisopropyl 8-(dialkylamino)-2,4-dicyano-3-(2-furyl)-6-oxobicyclo[3.2.1]octane-2,4-dicarboxylates. The tructure of the products was confirmed by NMR and X-ray analysis.
Dr. Enrique Cabaleiro Lago. Universidade de Santiago de Compostela. Spain
Dr. Mohammad G. Dekamin. Iran University of Science & Technology. Iran
Dr. Roman Dembinski. Oakland University. USA
Dr. Simona Funar-Timofei. Institute of Chemistry Timisoara of Romanian Academy. Romania
Dr. Fernanda Gadini Finelli . Universidade Federal do Rio de Janeiro. Brazil
Dr. Rocío Gámez Montaño. Universidad de Guanajuato. Mexico
Dr. Manik Ghosh. Birla Institute of Technology. India
Dr. Josef Jampílek. Faculty of Pharmacy, Comenius University in Bratislava, Slovakia
Dr. Maria Kneeteman. Universidad Nacional del Litoral. Argentina
Dr. Sachin Laddha. S.N.D.T. Women’s University. India
Dr. Elena López Lago. Universidade de Santiago de Compostela. Spain
Dr. Anna P. G. Nikalje. Dr Babasaheb Ambedkar Marathwada University. Dr.Rafiq Zakaria Campus, India
Dr. Juan Ortigueira Amor. Universidade de Santiago de Compostela. Spain
Dr. Pavel Pazdera. Masaryk University. Czech Republic
Dr. M. Manuela M. Raposo. Universidade do Minho. Portugal
Dr. Claudio Santi. University of Perugia. Italy
Dr. Miguel Angel Sierra. Real Sociedad Española de Química (RSEQ). Spain
Dr. Anatoly D. Shutalev. Moscow Technological University. Russian Federation
Dr. Victor Hugo Soto Tellini. University of Costa Rica. Costa Rica
Dr. Wolfgang Stadlbauer. University of Graz. Austria
Dr. Aravind Sivasubramanian. SASTRA University. India
Dr. Thies Thiemann. United Arab Emirates Univ. United Arab Emirates
Dr. Valérie Thiéry. Université de La Rochelle. France
Dr. Bai Yang. Jilin University. China
Dr. Noureddine Choukchou-Braham. Université Aboubakr Belkaid. Algeria